CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Evotec AG - EVT CFD

    18.260
    0.94%
    0.110
    Low: 18.06
    High: 18.56
    Market Trading Hours* (UTC) Opens on Monday at 08:00

    Mon - Fri: 08:00 - 16:30

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.110
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.022079 %
    Charges from full value of position ($-4.20)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.022079%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.000143 %
    Charges from full value of position ($-0.03)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.000143%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency EUR
    Margin 5%
    Stock exchange Germany
    Commission on trade 0%

    *Information provided by Capital.com

    Evotec SE ESG Risk Ratings

    High Medium Low Negligible

    ‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

    More ESG coverage

    Key Stats
    Prev. Close* 18.09
    Open* 18.335
    1-Year Change* 15.31%
    Day's Range* 18.06 - 18.56
    52 wk Range 14.80-24.44
    Average Volume (10 days) 319.40K
    Average Volume (3 months) 8.12M
    Market Cap 3.40B
    P/E Ratio -100.00K
    Shares Outstanding 176.94M
    Revenue 820.80M
    EPS -0.54
    Dividend (Yield %) N/A
    Beta 1.00
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 18.260 -0.080 -0.44% 18.340 18.595 18.005
    Dec 7, 2023 18.090 -0.470 -2.53% 18.560 18.560 18.090
    Dec 6, 2023 18.800 0.515 2.82% 18.285 18.895 17.985
    Dec 5, 2023 17.945 -0.160 -0.88% 18.105 18.350 17.765
    Dec 4, 2023 18.195 -0.120 -0.66% 18.315 18.960 18.105
    Dec 1, 2023 18.330 -0.285 -1.53% 18.615 18.700 17.910
    Nov 30, 2023 18.535 0.155 0.84% 18.380 18.560 18.030
    Nov 29, 2023 18.265 0.340 1.90% 17.925 18.325 17.850
    Nov 28, 2023 17.645 -0.325 -1.81% 17.970 18.045 17.645
    Nov 27, 2023 18.175 -0.430 -2.31% 18.605 18.920 18.115
    Nov 24, 2023 18.845 0.150 0.80% 18.695 18.885 18.560
    Nov 23, 2023 18.725 -0.275 -1.45% 19.000 19.035 18.385
    Nov 22, 2023 19.045 0.395 2.12% 18.650 19.135 18.610
    Nov 21, 2023 18.765 -0.370 -1.93% 19.135 19.160 18.610
    Nov 20, 2023 19.165 0.730 3.96% 18.435 19.275 18.265
    Nov 17, 2023 18.635 0.545 3.01% 18.090 18.815 18.090
    Nov 16, 2023 18.225 -0.435 -2.33% 18.660 18.940 18.200
    Nov 15, 2023 18.585 -0.115 -0.61% 18.700 18.965 18.335
    Nov 14, 2023 18.625 1.075 6.13% 17.550 18.735 17.410
    Nov 13, 2023 17.270 -0.080 -0.46% 17.350 17.705 17.270

    Evotec AG Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 751.448 618.034 500.924 446.437 375.405
    Revenue 751.448 618.034 500.924 446.437 375.405
    Cost of Revenue, Total 577.383 466.491 375.181 313.546 263.389
    Gross Profit 174.065 151.543 125.743 132.891 112.016
    Total Operating Expense 724.824 588.901 452.368 383.843 297.942
    Selling/General/Admin. Expenses, Total 156.19 105.445 77.205 66.546 57.012
    Research & Development 76.642 72.2 63.945 58.432 35.619
    Unusual Expense (Income) -5.774 12.546 3.244 11.919 -11.036
    Other Operating Expenses, Total -79.617 -67.781 -67.207 -66.6 -47.042
    Operating Income 26.624 29.133 48.556 62.594 77.463
    Interest Income (Expense), Net Non-Operating -179.854 208.106 -22.925 -6.102 -5.602
    Other, Net -0.727 -0.259 0.209 0.07 0.138
    Net Income Before Taxes -153.957 236.98 25.84 56.562 71.999
    Net Income After Taxes -175.655 215.51 6.278 37.228 84.056
    Minority Interest 0 0 0 0.844 0.116
    Net Income Before Extra. Items -175.655 215.51 6.278 38.072 84.172
    Net Income -175.655 215.51 6.278 38.072 84.172
    Income Available to Common Excl. Extra. Items -175.655 215.51 6.278 38.072 84.172
    Income Available to Common Incl. Extra. Items -175.655 215.51 6.278 38.072 84.172
    Diluted Net Income -175.655 215.51 6.278 38.072 84.172
    Diluted Weighted Average Shares 176.674 166.406 153.752 149.726 147.482
    Diluted EPS Excluding Extraordinary Items -0.99423 1.29509 0.04083 0.25428 0.57073
    Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
    Diluted Normalized EPS -1.01547 1.36365 0.05455 0.30667 0.52209
    Dilution Adjustment 0
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 170.279 213.556 240.689 173.884 172.203
    Revenue 170.279 213.556 240.689 173.884 172.203
    Cost of Revenue, Total 123.956 160.319 158.233 145.464 141.308
    Gross Profit 46.323 53.237 82.456 28.42 30.895
    Total Operating Expense 206.567 201.041 197.229 187.413 175.973
    Selling/General/Admin. Expenses, Total 45.609 42.583 46.332 42.462 35.83
    Research & Development 12.377 18.486 21.322 18.482 18.725
    Other Operating Expenses, Total 24.625 -20.347 -22.884 -18.995 -19.89
    Operating Income -36.288 12.515 43.46 -13.529 -3.77
    Interest Income (Expense), Net Non-Operating 5.261 -6.203 -60.362 -29.806 -20.131
    Other, Net 10.59 -12.527 -0.622 -0.029 -0.435
    Net Income Before Taxes -20.437 -6.215 -17.524 -43.364 -24.336
    Net Income After Taxes -14.929 -13.898 -27.201 -47.275 -27.937
    Net Income Before Extra. Items -14.929 -13.898 -27.201 -47.275 -27.937
    Net Income -14.929 -13.898 -27.201 -47.275 -27.937
    Income Available to Common Excl. Extra. Items -14.929 -13.899 -27.201 -47.275 -27.937
    Income Available to Common Incl. Extra. Items -14.929 -13.899 -27.201 -47.275 -27.937
    Diluted Net Income -14.929 -13.899 -27.201 -47.275 -27.937
    Diluted Weighted Average Shares 176.936 176.936 176.589 176.703 176.703
    Diluted EPS Excluding Extraordinary Items -0.08438 -0.07855 -0.15404 -0.26754 -0.1581
    Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
    Diluted Normalized EPS -0.08438 -0.07855 -0.17529 -0.26754 -0.1581
    Unusual Expense (Income) -5.774 0 0
    Minority Interest 0
    Total Adjustments to Net Income -0.001
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 1073.67 1100.94 658.844 469.53 249.769
    Cash and Short Term Investments 729.983 858.498 492.634 321.662 149.879
    Cash & Equivalents 415.155 699.326 422.58 277.034 109.055
    Short Term Investments 314.828 159.172 70.054 44.628 40.824
    Total Receivables, Net 256.737 176.754 122.221 117.844 74.772
    Accounts Receivable - Trade, Net 199.169 150.692 91.612 93.702 58.851
    Total Inventory 29.825 25.793 13.585 10.749 5.66
    Prepaid Expenses 40.178 19.21 9.258 9.166 8.451
    Other Current Assets, Total 16.948 20.685 21.146 10.109 11.007
    Total Assets 2257.25 2235.16 1462.34 1180.91 771.883
    Property/Plant/Equipment, Total - Net 650.201 484.597 337.297 239.229 90.519
    Property/Plant/Equipment, Total - Gross 920.81 686.086 481.879 350.415 164.143
    Accumulated Depreciation, Total -270.609 -201.489 -144.582 -111.186 -73.624
    Goodwill, Net 274.819 257.569 247.37 255.919 220.791
    Intangibles, Net 23.819 30.851 98.036 116.994 122.989
    Long Term Investments 150.332 287.009 59.021 41.252 28.99
    Note Receivable - Long Term 70.293 55.966 36.485 22.718 14.601
    Other Long Term Assets, Total 14.112 18.229 25.284 35.27 44.224
    Total Current Liabilities 337.706 324.516 208.459 178.955 196.275
    Accounts Payable 97.277 72.598 42.549 31.319 31.137
    Accrued Expenses 47.49 33.983 34.728 29.174 25.67
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 16.381 50.609 30.008 20.731 56.919
    Other Current Liabilities, Total 176.558 167.326 101.174 97.731 82.549
    Total Liabilities 1070.06 857.476 737.881 703.883 347.879
    Total Long Term Debt 490.293 462.308 461.957 442.368 57.546
    Long Term Debt 328.295 326.344 331.019 324.886 54.68
    Capital Lease Obligations 161.998 135.964 130.938 117.482 2.866
    Deferred Income Tax 18.524 17.688 20.399 21.199 21.517
    Minority Interest 0 0 0 0 0.876
    Other Liabilities, Total 223.54 52.964 47.066 61.361 71.665
    Total Equity 1187.18 1377.69 724.456 477.029 424.004
    Common Stock 176.953 176.608 163.915 150.903 149.063
    Additional Paid-In Capital 1440.01 1430.14 1030.7 786.865 783.154
    Retained Earnings (Accumulated Deficit) -392.377 -216.421 -432.639 -441.177 -481.013
    Unrealized Gain (Loss) -21.113 3.053 4.26 4.565 6.002
    Other Equity, Total -16.289 -15.691 -41.782 -24.127 -33.202
    Total Liabilities & Shareholders’ Equity 2257.25 2235.16 1462.34 1180.91 771.883
    Total Common Shares Outstanding 176.703 176.358 163.665 150.653 148.813
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 939.198 1026.45 1073.67 1095.82
    Cash and Short Term Investments 619.18 632.973 729.983 828.795
    Cash & Equivalents 499.366 459.752 415.155 463.913
    Short Term Investments 119.814 173.221 314.828 364.882
    Total Receivables, Net 219.371 291.301 256.737 187.997
    Accounts Receivable - Trade, Net 161.105 228.955 199.169 140.631
    Total Inventory 31.906 32.612 29.825 30.874
    Prepaid Expenses 68.741 69.563 57.126 48.15
    Total Assets 2254.51 2301.22 2257.25 2262.66
    Property/Plant/Equipment, Total - Net 763.899 721.136 650.201 600.499
    Goodwill, Net 274.819 278.417
    Intangibles, Net 291.055 292.612 23.819 25.736
    Long Term Investments 151.62 160.842 150.332 189.245
    Note Receivable - Long Term 98.685 88.8 70.293 56.911
    Other Long Term Assets, Total 10.052 11.382 14.112 16.039
    Total Current Liabilities 434.045 488.107 337.706 340.802
    Accounts Payable 96.774 106.038 97.277 83.965
    Notes Payable/Short Term Debt 0 0 0 0
    Current Port. of LT Debt/Capital Leases 144.287 151.638 16.381 14.108
    Other Current Liabilities, Total 192.984 230.431 224.048 242.729
    Total Liabilities 1113.69 1126.93 1070.06 1034.14
    Total Long Term Debt 444.455 382.509 490.293 477.984
    Long Term Debt 444.455 382.509 328.295 326.776
    Capital Lease Obligations 161.998 151.208
    Deferred Income Tax 18.603 19.13 18.524 17.179
    Other Liabilities, Total 216.587 237.188 223.54 198.173
    Total Equity 1140.82 1174.29 1187.18 1228.53
    Common Stock 177.186 177.186 176.953 176.953
    Additional Paid-In Capital 1446.47 1445.36 1440.01 1437.55
    Retained Earnings (Accumulated Deficit) -482.836 -448.256 -392.377 -364.631
    Other Equity, Total -16.289 -21.348
    Total Liabilities & Shareholders’ Equity 2254.51 2301.22 2257.25 2262.66
    Total Common Shares Outstanding 176.936 176.936 176.703 176.703
    Unrealized Gain (Loss) -21.113
    Minority Interest 0 0 0 0
    Other Current Assets, Total 0.001
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -175.655 215.51 6.252 37.228 84.056
    Cash From Operating Activities 203.106 122.237 44.721 42.216 156.24
    Cash From Operating Activities 72.677 55.596 42.122 36.456 19.288
    Amortization 8.982 12.012 13.936 12.349 12.005
    Deferred Taxes 7.722 5.066 7.49 6.706 -26.117
    Non-Cash Items 195.391 -165.371 23.865 24.342 0.364
    Cash Taxes Paid 18.5 -6.028 9.796 2.417 3.596
    Cash Interest Paid 9.798 5.429 3.465 4.49 2.279
    Changes in Working Capital 93.989 -0.576 -48.944 -74.865 66.644
    Cash From Investing Activities -415.823 -243.855 -155.089 -86.634 -39.13
    Capital Expenditures -181.354 -118.943 -99.072 -31.905 -27.867
    Other Investing Cash Flow Items, Total -234.469 -124.912 -56.017 -54.729 -11.263
    Cash From Financing Activities -52.414 398.43 246.409 211.263 -77.764
    Financing Cash Flow Items
    Issuance (Retirement) of Stock, Net 0.699 404.322 251.564 1.901 1.578
    Issuance (Retirement) of Debt, Net -53.113 -5.892 -5.155 209.362 -79.342
    Foreign Exchange Effects -19.04 -0.066 9.505 1.134 2.692
    Net Change in Cash -284.171 276.746 145.546 167.979 42.038
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Net income/Starting Line -175.655 -148.454 -101.179 -73.242 215.51
    Cash From Operating Activities 203.106 236.633 240.607 63.618 122.237
    Changes in Working Capital 378.761 385.087 341.786 136.86 -93.273
    Cash From Investing Activities -415.823 -435.034 -206.857 -95.732 -243.855
    Capital Expenditures -181.354 -157.21 -81.371 -42.921 -118.943
    Other Investing Cash Flow Items, Total -234.469 -277.824 -125.486 -52.811 -124.912
    Cash From Financing Activities -52.414 -50.454 -45.805 -5.279 398.43
    Issuance (Retirement) of Stock, Net 0.699 0.355 0.7 0.345 404.322
    Issuance (Retirement) of Debt, Net -53.113 -50.809 -46.505 -5.624 -5.892
    Foreign Exchange Effects -19.04 13.442 9.721 -1.445 -0.066
    Net Change in Cash -284.171 -235.413 -2.334 -38.838 276.746
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Novo Holdings A/S Venture Capital 9.8455 17444807 -206374 2022-12-31 LOW
    Government of Abu Dhabi Government Agency 6.5913 11678875 199342 2022-12-31 LOW
    T. Rowe Price Associates, Inc. Investment Advisor 5.0131 8882485 36011 2023-09-21 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 3.5645 6315718 2452073 2023-06-16 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.5926 4593730 1224 2023-09-30 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.2224 3937850 851779 2022-12-31 LOW
    Brown Capital Management, LLC Investment Advisor 2.1752 3854173 18059 2023-03-31 LOW
    Liontrust Investment Partners LLP Investment Advisor 2.0301 3597021 -37024 2023-08-31 LOW
    Allianz Global Investors GmbH Investment Advisor 1.84 3260133 10629 2023-08-31 LOW
    Oetker (Roland) Individual Investor 1.639 2904146 -5440854 2022-10-04 LOW
    BlackRock Asset Management Deutschland AG Investment Advisor 1.5298 2710589 -5722 2023-09-30 LOW
    Franklin Equity Group Investment Advisor 1.2699 2250000 0 2023-09-30 LOW
    Polar Capital LLP Investment Advisor/Hedge Fund 1.1488 2035438 0 2023-06-30 LOW
    Deka Investment GmbH Investment Advisor/Hedge Fund 1.1055 1958807 -3463 2023-09-30 LOW
    California State Teachers Retirement System Pension Fund 1.0986 1946619 1704482 2022-06-30 LOW
    Evotec SE Management Corporation 0.9987 1769527 0 2022-12-31 LOW
    DWS Investment GmbH Investment Advisor/Hedge Fund 0.8748 1549952 4235 2023-09-30 LOW
    Baillie Gifford & Co. Investment Advisor 0.7134 1263957 -38325 2023-08-31 LOW
    T. Rowe Price International Ltd Investment Advisor/Hedge Fund 0.6168 1092871 -24740 2023-09-30 LOW
    Lupus alpha Asset Management AG Investment Advisor/Hedge Fund 0.5858 1038000 -105000 2023-06-30 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Evotec Company profile

    About Evotec SE

    Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

    Financial summary

    BRIEF: For the nine months ended 30 September 2021, Evotec SE revenues increased 20% to EUR431M. Net income increased from EUR5.8M to EUR247M. Revenues reflect EVT Execute segment increase of 22% to EUR329M, EVT Innovate segment increase of 36% to EUR101.9M, United States segment increase of 32% to EUR142.9M, Others segment increase of 30% to EUR47.5M, United Kingdom segment increase of 8% to EUR47.2M.

    Industry: Biotechnology & Medical Research (NEC)

    Essener Bogen 7
    HAMBURG
    HAMBURG 22419
    DE

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    XRP/USD

    0.63 Price
    -6.600% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Gold

    1,996.96 Price
    -0.400% 1D Chg, %
    Long position overnight fee -0.0199%
    Short position overnight fee 0.0117%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    BTC/USD

    42,218.15 Price
    -4.110% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    US100

    16,039.80 Price
    -0.230% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading